Recent advances in autoimmune pancreatitis

Gut

Volumn 58, Issue 12, 2009, Pages 1680-1689

  Park, D H ^a   Kim, M H ^a   Chari, S T ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G4; STEROID;

ARTICLE; AUTOIMMUNE PANCREATITIS; CELLULAR IMMUNITY; CHRONIC PANCREATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EFFECTOR CELL; ENDOSCOPIC ECHOGRAPHY; GENETIC ASSOCIATION; GRANULOCYTE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS BIOPSY; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; SERODIAGNOSIS; TYPE 1 AUTOIMMUNE PANCREATITIS; TYPE 2 AUTOIMMUNE PANCREATITIS;

AGED; ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOCORTICOIDS; HUMANS; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; PANCREATITIS, CHRONIC;

EID: 70349530416     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.155853     Document Type: Article

References (89)

1. Sarles H, Sarles JC, Muratore R, et al. Chronic inflammatory sclerosis of the pancreas - an autonomous pancreatic disease? Am J Dig Dis 1961;6:688-698
2. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561-1568
3. Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol 2003;27:1119-1127 (Pubitemid 36909533)
4. Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004;445:552-563 (Pubitemid 40104530)
5. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002;51:1-4.
6. Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991;22:387-395
7. Kamisawa T. IgG4-positive plasma cells specifically infiltrate various organs in autoimmune pancreatitis. Pancreas 2004;29:167-168 (Pubitemid 38971809)
8. Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007;20:23-28 (Pubitemid 44967946)
9. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-738
10. Chari S, Murray JA. Autoimmune pancreatitis. Part II: the relapse. Gastroenterology 2008;134: 625-628
11. Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 2003;98:2811-2812
12. Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997;41:263-268
13. Kloppel G. Chronic pancreatitis, pseudotumors and other tumorlike lesions. Mod Pathol 2007;20(Suppl 1):S113-31.
14. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006;4:1010-1016 (Pubitemid 44118845)
15. Kamisawa T, Egawa N, Nakajima H, et al. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2003;98:2694-2699 (Pubitemid 38020110)
16. Church NI, Pereira SP, Deheragoda MG, et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 2007;102:2417-2425
17. Kim KP, Kim MH, Song MH, et al. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004;99:1605-1616
18. Nishimura T, Masaoka T, Suzuki H, et al. Autoimmune pancreatitis with pseudocysts. J Gastroenterol 2004;39:1005-1010
19. Gardner TB, Chari ST. Autoimmune pancreatitis. Gastroenterol Clin North Am 2008;37:439-60, vii.
20. Kamisawa T, Imai M, Yui Chen P, et al. Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas 2008;37:e62-7.
21. Horiuchi A, Kawa S, Hamano H, et al. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 2002;55:494-499 (Pubitemid 41123499)
22. Farrell JJ, Garber J, Sahani D, et al. EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc 2004;60:927-936 (Pubitemid 39655467)
23. Levy MJ, Reddy RP, Wiersema MJ, et al. EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest Endosc 2005;61:467-472
24. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002;51:1-4.
25. Okazaki K, Uchida K, Fukui T. Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol 2008;43:409-418 (Pubitemid 351997877)
26. Choi EK, Kim MH, Lee TY, et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas 2007;35:156-161
27. Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007;102:1646-1653 (Pubitemid 47206688)
28. Raina A, Krasinskas AM, Greer JB, et al. Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med 2008;132:48-53.
29. Kamisawa T, Matsukawa M, Ohkawa M. Autoimmune pancreatitis associated with retroperitoneal fibrosis. JOP 2005;6:260-263 (Pubitemid 41573809)
30. Kamisawa T, Nakajima H, Hishima T. Close correlation between chronic sclerosing sialadenitis and immunoglobulin G4. Intern Med J 2006;36:527-529 (Pubitemid 43990906)
31. Takahashi N, Kawashima A, Fletcher JG, et al. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 2007;242:791-801. (Pubitemid 46310092)
32. Björnsson E, Chari ST, Smyrk TC, et al. IgG4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology 2007;45:1547-1554 (Pubitemid 46918339)
33. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4- associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008;134:706-715 (Pubitemid 351312724)
34. Nakazawa T, Ohara H, Sano H, et al. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas 2006;32:229.
35. Society MotCCfAPotJP. Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society. J Jpn Pancreas (Suizou) 2002;17:587.
36. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006;41:626-631 (Pubitemid 44288525)
37. Kwon S, Kim MH, Choi EK. The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus. Pancreas 2007;34:279-286 (Pubitemid 46588252)
38. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008;43:403-408 (Pubitemid 351997876)
39. Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol 2006;30:1537-1545 (Pubitemid 44808790)
40. Kamisawa T, Yoshiike M, Egawa N, et al. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005;5:234-8; discussion 8-40.
41. Moon SH, Kim MH, Park DH, et al. Is a two-week steroid trial after initial negative workup for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 2008;57:1704-1712
42. Gardner TB, Levy MJ, Takahashi N, et al. Misdiagnosis of autoimmune pancreatitis: a caution to clinicians. Am J Gastroenterol 2008;104:1620-1623
43. Levy P, Hammel P, Ruszniewski P. Diagnostic challenge in autoimmune pancreatitis: beware of shipwreck! Gut 2008;57:1646-1647
44. Ghazale A, Chari ST. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 2007;56:1650-1652 (Pubitemid 350206287)
45. Ghazale A, Chari S. Is Autoimmune pancreatitis a risk factor for pancreatic cancer? Pancreas 2007;35:376.
46. Finkelberg DL, Sahani D, Deshpande V, et al. Autoimmune pancreatitis. N Engl J Med 2006;355:2670-2676
47. Okazaki K. Autoimmune pancreatitis: etiology, pathogenesis, clinical findings and treatment. The Japanese experience. JOP 2005;6:89-96.
48. Okazaki K, Uchida K, Chiba T. Recent concept of autoimmune-related pancreatitis. J Gastroenterol 2001;36:293-302.
49. Kloppel G, Sipos B, Zamboni G, et al. Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol 2007;42(Suppl 18):28-31. (Pubitemid 46863934)
50. Kawa S, Ota M, Yoshizawa K, et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002;122:1264-1269 (Pubitemid 34465169)
51. Park do H, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology 2008;134:440-446
52. Chang MC, Chang YT, Tien YW, et al. T-cell regulatory gene CTLA- 4 polymorphism/haplotype association with autoimmune pancreatitis. Clin Chem 2007;53:1700-1705
53. Umemura T, Ota M, Hamano H, et al. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol 2008;103:588-594
54. Nishimori I, Miyaji E, Morimoto K, et al. Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut 2005;54:274-281 (Pubitemid 40139246)
55. Aparisi L, Farre A, Gomez-Cambronero L, et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 2005;54:703-709 (Pubitemid 40559259)
56. Kino-Ohsaki J, Nishimori I, Morita M, et al. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogren's syndrome. Gastroenterology 1996;110:1579-1586 (Pubitemid 26134092)
57. Haneji N, Nakamura T, Takio K, et al. Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 1997;276:604-607 (Pubitemid 27193686)
58. Horiuchi AKS, Hamano H, Akamatsu T, et al. Clinicopathological features of 22 Japanese patients with autoimmune pancreatitis. Gastroenterology 2000;118:422.
59. Asada M, Nishio A, Uchida K, et al. Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis. Pancreas 2006;33:20-26 (Pubitemid 43995335)
60. Ghazale A, Chari S, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007;102:1646-1653 (Pubitemid 47206688)
61. Zhang L, Chari ST, Levy MJ, et al. Pancreatic IgG4 stain for diagnosing autoimmune pancreatitis (AIP) and for distinguishing AIP subtypes. Gastroenterology 2005;128:A-474.
62. Okazaki K, Uchida K, Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000;118:573-581 (Pubitemid 30140856)
63. Shi HN, Walker WA. T helper cell subclasses and clinical disease states. Curr Opin Gastroenterol 2002;18:711-716
64. Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007;45:1538-1546 (Pubitemid 46918338)
65. Kamisawa T, Okamoto A, Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas 2005;31:28-31. (Pubitemid 40911499)
66. Muraki T, Hamano H, Ochi Y, et al. Autoimmune pancreatitis and complement activation system. Pancreas 2006;32:16-21. (Pubitemid 41803642)
67. Kawa S, Kitahara K, Hamano H, et al. A novel immunoglobulin- immunoglobulin interaction in autoimmunity. PLoS ONE 2008;3:e1637.
68. Kountouras J, Zavos C, Gavalas E, et al. Challenge in the pathogenesis of autoimmune pancreatitis: potential role of Helicobacter pylori infection via molecular mimicry. Gastroenterology 2007;133:368-369 (Pubitemid 47031162)
69. Kountouras J, Zavos C, Chatzopoulos D. A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis. J Cell Mol Med 2005;9:196-207.
70. Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J Cell Mol Med 2005;9:741-744
71. Valencia X, Lipsky PE. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol 2007;3:619-626
72. Bacchetta R, Gambineri E, Roncarolo MG. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol 2007;120:227-35; quiz 36-37
73. Gottenberg JE, Lavie F, Abbed K, et al. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjogren's syndrome. J Autoimmun 2005;24:235-242 (Pubitemid 40545886)
74. Maul J, Loddenkemper C, Mundt P, et al. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 2005;128:1868-1878.
75. Bonelli M, von Dalwigk K, Savitskaya A, et al. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus (SLE): a comparative phenotypic analysis. Ann Rheum Dis 2007;67:664-671 (Pubitemid 351571931)
76. Miyoshi H, Uchida K, Taniguchi T, et al. Circulating naive and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis. Pancreas 2008;36:133-140
77. Davidson TS, Longnecker DS, Hickey WF. An experimental model of autoimmune pancreatitis in the rat. Am J Pathol 2005;166:729-736 (Pubitemid 40315630)
78. Kojima M, Sipos B, Klapper W, et al. Autoimmune pancreatitis: frequency, IgG4 expression, and clonality of T and B cells. Am J Surg Pathol 2007;31:521-528 (Pubitemid 46569035)
79. Tsubata R, Tsubata T, Hiai H, et al. Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjogren's syndrome. Eur J Immunol 1996;26:2742-2748 (Pubitemid 26364854)
80. Qu WM, Miyazaki T, Terada M, et al. A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic:polycytidylic acid. Clin Exp Immunol 2002;129:27-34.
81. Hahm KB, Im YH, Lee C, et al. Loss of TGF-beta signaling contributes to autoimmune pancreatitis. J Clin Invest 2000;105:1057-1065 (Pubitemid 30217690)
82. Nishimori I, Bratanova T, Toshkov I, et al. Induction of experimental autoimmune sialoadenitis by immunization of PL/J mice with carbonic anhydrase II. J Immunol 1995;154:4865-4873
83. Ueno Y, Ishii M, Takahashi S, et al. Different susceptibility of mice to immune-mediated cholangitis induced by immunization with carbonic anhydrase II. Lab Invest 1998;78:629-637 (Pubitemid 28246986)
84. Sakaguchi Y, Inaba M, Tsuda M, et al. The Wistar Bonn Kobori rat, a unique animal model for autoimmune pancreatitis with extrapancreatic exocrinopathy. Clin Exp Immunol 2008;152:1-12. (Pubitemid 351347541)
85. Meagher C, Tang Q, Fife BT, et al. Spontaneous development of a pancreatic exocrine disease in CD28-deficient NOD mice. J Immunol 2008;180:7793-7803
86. Gouni-Berthold I, Baumeister B, Berthold HK, et al. Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease. Hepatogastroenterology 1999;46:1720-1723 (Pubitemid 29366331)
87. MacDermott RP, Nash GS, Auer IO, et al. Alterations in serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease. Gastroenterology 1989;96:764-768 (Pubitemid 19057597)
88. Kanno H, Nose M, Itoh J, et al. Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism. Clin Exp Immunol 1992;89:68-73.
89. Uchida K, Okazaki K, Nishi T, et al. Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin. Lab Invest 2002;82:411-424 (Pubitemid 34311114)